Ranked #1 Children's Hospital by U.S. News & World Report
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
There are many ways you can help children and their families get the care they need.
What is acute lymphoblastic leukemia (ALL)?
In the form of leukemia known as acute lymphoblastic leukemia (ALL), a group of white blood cells called lymphocytes is affected. It is also sometimes called acute lymphocytic leukemia or lymphoid leukemia. ALL accounts for about 75 to 80 percent of the childhood leukemias. Leukemia is the most common form of cancer in children, affecting about 3,000 children each year in the United States, accounting for about 30 percent of childhood cancers.
How Dana-Farber/Boston Children's approaches acute lymphoblastic leukemia
Children with acute lymphoblastic leukemia are treated through the Leukemia Program at Dana-Farber/Boston Children's Cancer and Blood Disorders Center. Dana-Farber/Boston Children’s has played a key role in refining treatment for childhood leukemia, resulting in today's cure rates of more than 85 percent for pediatric acute lymphoblastic leukemia (ALL). We continue to lead leukemia clinical trials designed to increase cure rates, decrease treatment-related side effects and improve care for long-term survivors.
Find in-depth information on acute lymphoblastic leukemia (ALL) on the Dana-Farber/Boston Children’s website, including answers to:
The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”